A new kind of single-dose vaccine that comes in a nasal spray and doesn’t require refrigeration could dramatically alter the public health landscape — get more people vaccinated around the world and address the looming threats of emerging and re-emerging diseases.
Researchers presented the latest design and testing of these “nanovaccines” at the 247th National Meeting & Exposition of the American Chemical Society (ACS), the world’s largest scientific society.
Their talk was one of more than 10,000 presentations at the meeting, being held here through Thursday at the Dallas Convention Center and area hotels.
“Our nanovaccine approach could be instrumental for containing future outbreaks of recently emerged and re-emerging diseases, such as SARS, new flu strains and multi-drug resistant tuberculosis,” said Balaji Narasimhan, Ph.D., the project’s lead researcher.
He noted that most of today’s vaccines require needles, boosters and refrigeration, all of which pose challenges for doctors and patients. Other than the pain factor, which can lower the chances that someone will seek out a vaccine, follow-up shots and refrigeration further reduce the reach of these vitally important preventive treatments. In some places with limited resources, refrigeration simply isn’t available. Thus, many people who need vaccinations the most aren’t getting them at all. The good news is that the vaccines Narasimhan’s team is developing don’t need to be kept cold and are easy to administer.
“Our nanovaccines can be stored at room temperature for as long as six to 10 months and still work,” said Narasimhan, who’s at Iowa State University. “Also, we’re designing them so they get delivered in one dose through a nasal spray, which could potentially allow patients to give the vaccine to themselves.”
Another major limitation of traditional vaccines is the way they work, he said. Most current vaccines help a person develop disease immunity by introducing part of a virus or bacteria and triggering the body’s humoral response — the part of the immune system that produces antibodies to fight off a harmful pathogen. Later, if the person gets infected by that microbe, the body immediately knows how to respond.
But increasingly, evidence is emerging that the other component of the body’s immune system, what’s called the cell-mediated arm, also plays an important part in some emerging and re-emerging diseases, such as whooping cough. This side of the immune system depends on a group of cells called T cells, rather than antibodies, to fight viruses and bacteria.
Part of the elegance of these nanovaccines is their simplicity and versatility, Narasimhan explained. They are made of only two components: bits of proteins from a virus or bacteria packed into nontoxic, biodegradable polymers that can be custom-designed.
When administered through the nose or by a shot, these tiny packages enter the body and flag the immune system. Sentinels called antigen-presenting cells that keep watch in the body for foreign invaders gobble up the nanovaccine particles, chop up the polymers and pathogen proteins, and appropriately put pieces of the proteins on their surfaces. Depending on the chemistry of the nanovaccine, this triggers the body’s cell-mediated or humoral immune response and trains it to recognize the pathogen and attack it quickly in case of future infections.
“We have exciting results that attest to the ability of the nanovaccine formulations to do a very good job of activating cell-mediated immunity,” said Narasimhan. “We’ve shown that it works with rodents, and we’re moving forward to show that in larger animals, as well.”
The Latest on: Spray vaccine
[google_news title=”” keyword=”Spray vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Spray vaccine
- Study: Pineapple-flavored mouth spray vaccine might stop UTIs for yearson May 2, 2024 at 5:43 am
One participant, however, had to stop using the spray because of an allergic reaction that led to rashes on her face and neck. Experts say more research is needed to determine the safety and efficacy ...
- Study: Pineapple-flavored mouth spray vaccine might stop UTIs for yearson May 2, 2024 at 4:00 am
had to stop using the spray because of an allergic reaction that led to rashes on her face and neck. Experts say more research is needed to determine the safety and efficacy of the vaccine ...
- Hong Kong residents urged to get influenza vaccines after the death of a third child this yearon April 29, 2024 at 5:00 pm
Hong Kong health officials are reaching out to city residents, telling them to get themselves vaccinated against the flu after a third child died from the infection this year. Authorities have warned ...
- New UTI vaccine wards off infection for years, early studies suggeston April 26, 2024 at 12:39 pm
More than 50% of the patients who used a new mouth-spray-based vaccine didn't have a UTI for up to nine years.
- New UTI vaccine wards off infection for years, early studies suggeston April 25, 2024 at 5:00 pm
More than 50% of the patients who used a new mouth-spray-based vaccine didn't have a UTI for up to nine years. A new mouth-spray vaccine reportedly stops urinary tract infections (UTIs ...
- A one-shot vaccine for COVID, flu and future viruses? Researchers say it's comingon April 17, 2024 at 10:31 pm
Furthermore, this new vaccine would likely be delivered as a spray. As Salon has previously reported, vaccines that don’t require needles may one day become standard. This intriguing report ...
- Vaccine Breakthrough Could Mean Future-Proof Shots With No Need For Boosterson April 17, 2024 at 5:00 pm
They plan to develop a nasal spray vaccine, to avoid some of the issues and fears associated with needles. “Our next step is to use this same concept to generate a flu vaccine, so infants can be ...
- Genetics-based universal vaccine could be effective against any viral strainon April 16, 2024 at 3:32 am
Related Chlamydia vaccine triggers immune response in early trial Oral spray vaccine prevents recurrence of UTIs, study shows Pancreatic cancer vaccine prevents recurrence for three years in small ...
- 'One and Done': Scientists Develop Vaccine That May Fight Any Viral Strainon April 16, 2024 at 12:33 am
The new vaccine could also be delivered in the form of a spray, which will help people who are needle-shy. “Respiratory infections move through the nose, so a spray might be an easier delivery ...
- MV140: The Oral Spray Revolutionizing UTI Preventionon April 13, 2024 at 9:23 am
MV140 oral spray vaccine reduces UTIs by 54% It contains four types of inactivated bacteria, including E. coli It Offers hope for long-term relief from recurrent UTIs In a study conducted by the ...
via Bing News